A top dealmaker at the Chinese tech giant shares his insights into unearthing the next generation of ecosystem investment opportunities.
Prominent global investor calls out a growing and contentious business practise in China as these capitalise on their investment rights in later-stage venture capital deals.
Pushing out its Asian footprint and looking at new debt products, CLSA is chasing new opportunities along the Belt and Road and in India.
The JV between Alibaba and SAIC Motor becomes financially independent as it raises $233 million from a public fundraising – its first – to develop intelligent in-car systems.
As Asia marks a decade since being swept up in the Global Financial Crisis, we look at some of the key moments both before and since those monumental events.
Deal flow set to pick up if regulatory hold ups are resolved and markets play ball.
The private equity firm plans to help the pharmaceutical firm expand in China.
As the 10th anniversary of the Global Financial Crisis looms large, the veteran Asia banker sees opportunity for profit in the emerging markets crash and is planning to expand in 'sexy' private markets.
The US-China Green Fund has spent $400 million in search of the next big thing in ESG investing – and it’s not what you might think.
The Shanghai-London scheme expected to launch this year could help local Chinese investors turn their portfolios into more global ones with less regulatory and forex risk.
A huge offer for the fast-food chain operator is reminiscent of club deals in the 2006 to 2007 buyout boom — a salutary reminder on the 10th anniversary of the Global Financial Crisis.
The Hangzhou-headquartered startup raises $578 million as investors continue to chase opportunities in the Chinese online car marketplace – providing they are private.
While China's consumers love e-payments, few contracts are sealed digitally. Start-ups are trying to change all that, and international investors are putting their money behind it.
Hong Kong-listed environmental company raises $500 million from its debut convertible debt issue and offered investors an alternative against the bulk of outstanding papers from the property sector.
Singapore’s state fund leads $85 million funding for Harbour BioMed, marking its third investment in the Chinese pharmaceutical space in four months.
The Canadian pension fund and Australian property developer have increased their firepower for deals ahead of a 5G rollout that is set to deliver a major fillip to Chinese e-commerce.
The company that once aspired to be China's Netflix agrees a deal on debt with Shenzhen listed Leshi. But Leshi, toiling under a $1 billion debt mountain, is not out of the woods.
Chinese companies have experienced multiple setbacks with their outbound M&A and that is unlikely to change soon, but there is room for smaller deals.
Former chief of the Nasdaq-listed biotechnlogy firm launches a $3.9 billion bid to take it private. His consortium of backers face a potential battle to bring back ownership to China.
The submission deadline for FinanceAsia's inaugural China Awards has been extended to the end of August. Don't miss your chance to take part.